Related Experiment Videos
Immunological changes in acute myocardial infarction
Randa S Al-Ahmad1, Azmi M Mahafzah, Eyas N Al-Mousa
1Department of Pathology, Microbiology and Forensic Medicine, Faculty of Medicine, University of Jordan, Amman, Jordan.
Saudi Medical Journal
|July 6, 2004
Summary
Changes in cardiac troponin I (cTnI) and T-lymphocyte subsets indicate prognosis in acute myocardial infarction (AMI). These immunologic markers correlate with infarction extent but not with disease risk factors or vessel count.
Area of Science:
- Cardiology
- Immunology
Background:
- Acute myocardial infarction (AMI) involves complex pathophysiological processes.
- Understanding immune system responses in AMI is crucial for prognosis.
Purpose of the Study:
- To investigate changes in troponin and lymphocyte subsets following AMI.
- To correlate these immunological changes with clinical variables and disease severity.
Main Methods:
- Studied 45 AMI patients and 45 controls.
- Utilized flow cytometry for lymphocyte subset analysis (CD3+, CD4+, CD8+, CD19+).
- Measured serum cardiac troponin I (cTnI) using microparticle enzyme immunoassay.
Main Results:
- AMI patients showed increased CD8+ and CD19+ cells, decreased CD3+, CD4+ cells, and a lower CD4+/CD8+ ratio.
- Elevated cTnI levels correlated with decreased CD4+ cells and CD4+/CD8+ ratio, suggesting correlation with infarction extent.
- Low CD4+ cell percentages and CD4+/CD8+ ratio were poor prognostic indicators for AMI.
Conclusions:
- Immunological alterations, specifically T-lymphocyte subset shifts and cTnI levels, serve as prognostic markers in AMI.
- These markers are independent of traditional AMI risk factors and the number of diseased coronary vessels.